CASP3 and female reproductive organ cancer: To determine the potential relevance of these findings in other gynecological cancer cells, we used the caspase-3/7 activity assay to test the effects of TM on cisplatin sensitivity in SiHa cervical and cisplatin-resistant A2780CIS ovarian cancer cells.